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1 Janssen-Ortho Inc, Toronto, ON, Canada;
2 Damos Inc, Toronto, ON, Canada OBJECTIVES: To quantify the effect of galantamine on burden of caregivers of patients with Alzheimer's Disease (AD) enrolled in INSPIRE (Investigation in a Naturalistic Setting of Patients Initiated on Reminyl). METHODS: INSPIRE is a prospective, observational study conducted across Canada in general practice and specialist sites, involving 471 patients 65 years or older with mild to moderate AD. Patient and caregiver demographics were recorded at baseline, with effectiveness measured by the MiniMental State Examination (MMSE) and Physician's Clinical Global Impression-Disease Status (CGI) at both baseline visit and final visit at 3 months. Caregiver stress was assessed using the Zarit Burden Interview (ZBI). Analysis was based on twosided paired t-test. RESULTS: This preliminary analysis included 248 patients and caregivers, all of whom had completed the study at time of analysis. Of these patients, the mean age was 80.6 ± 6.5, 61% were female, 54% had a high school degree or less, and 74% lived with their spouse or partner. The mean age of caregivers was 61.4 ± 14.6. The caregiver sample was predominately female (75%), most lived with the patient (54%), and 42% employed on a full-time or part-time basis. At baseline, the mean caregiver ZBI score was 21.5 ± 12.6. Significant improvement in caregiver burden (mean change 1.5 ± 8.4, p = 0.006) was shown after three months of galantamine treatment.
CONCLUSIONS:
The efficacy and safety of galantamine has been demonstrated in multiple randomized, double-blind, placebo-controlled trials in patients with mild-to-moderate AD. This naturalistic study shows that galantamine significantly reduces burden among caregivers of patients with AD. Overall, galantamine has a broad ranging beneficial effect from both patient and caregiver perspectives. 
PMH16 EFFECT OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD) ON COST OF CARE IN THE CANADIAN OUTCOMES STUDY IN DEMENTIA

OBJECTIVES:
To determine the contribution of behavioural symptoms to the costs associated with caring for patients with dementia. METHODS: Data from the Canadian Outcomes Study in Dementia (COSID), a 3-year prospective study of community-dwelling dementia patients was examined. Cognition was assessed with the Mini-Mental State Examination (MMSE) and behaviour with the Neuropsychiatry Inventory (NPI). Resource utilization was evaluated monthly with caregivercompleted resource use (RU) questionnaires, which included frequency of community resource use (e.g., home care nurses, Meals-on-Wheels, etc.), hospitalization and respite care, outpatient visits and drug use (direct costs), as well as questions about time away from work or leisure activities for both patient and caregiver (indirect costs). Costs were calculated in 2000 Canadian dollars. RESULTS: Five hundred dementia patients and their caregivers who provided a minimum of 6 of 12 completed RU questionnaires were included in this 1-year preliminary analysis. At baseline, average age of patients was 76.3 (±6.3), 47% were male, and 82% were diagnosed with AD. Average MMSE was 22.4 (±4.5) and average NPI 8.8 (±11.1; range 0-69). Total costs were estimated at $1298 per month ($113 for medication costs, $237 for other direct costs, and $948 for indirect costs). An analysis of covariance model, that included NPI, MMSE, gender, age, marital status, dementia diagnosis, type of residence, region of Canada, and number of medical comorbidities, showed that greater cognitive impairment, i.e., lower MMSE (F = 12.77, p < 0.0004), female gender (F = 9.31, p = 0.0024) and non-AD dementia diagnosis (F = 6.27, p = 0.0126) were significant covariates. After accounting for the covariates, there was a significant association between cost and NPI (F = 22.46, p < 0.0001). The incremental cost of a one-point increase in NPI score was $32 per month (95% CI $18-$45). CONCLUSIONS: Behavioural and psychological symptoms of dementia (BPSD) contribute significantly to the total costs of caring for community dwelling dementia patients. (FSS) . Carers also answered the Caregiver Burden Interview of Zarit (ZS). RESULTS: Mean PCS and MCS scores of carers were 48.4 ± 13.8 and 48.0 ± 11.3 respectively. Multiple regression analysis showed that the variables associated to lower PCS of the carer were: higher ZS and older patient age (R2 = 0.15; p < 0.001). Variables associated to lower MCS were: higher ZS and lower FSS of the carer, and lower MCS of the patient (R2 = 0.29; p < 0.001). Variables associated to a higher ZS of carers were: lower FSS and lower PCS and MCS scores of the carer and higher age and lower PCS and MCS scores of the patient (R2 = 0.49; p < 0.001). Carers with a MCS =< 42 points (cutoff point associated with depression) were 28.3% (95%CI = 22.4-34.8). Logistic regression analysis
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